Browsing by Author Musgrove, Elizabeth A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2010The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5Clarke, Christine; Graham, J. Dinny; Alles, M. Chehani; Blazek, K; Caldon, C. E.; Cowley, M; Daly, Roger; Hilton, H; Kalyuga, M; Kaplan, Warren; Lee, H; Musgrove, Elizabeth A.; Naylor, M; Ormandy, Christopher J.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteThe Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5, Molecular Endocrinology, vol.24, 7,pp 1380-1392
2009BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastMcNeil, Catriona; O'Toole, Sandra; Anderson, Luke R.; Biankin, Andrew V.; Butt, Alison Joy; Crea, P; Henshall, Susan M.; Millar, E.; Morey, Adrienne; Musgrove, Elizabeth A.; Pinese, Mark; Sutherland, Robert L.; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyBAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast, British Journal of Cancer, vol.100, 1,pp 123-133
2013Clinical and molecular characterization of HER2 amplified-pancreatic cancerGill, Anthony; Toon, Christopher; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Cowley, Mark; Goldstein, David; Grimmond, Sean Michael; Humphris, Jeremy; Johns, Amber; Kassahn, Karin; Mead, Scott; Miller, David K; Morey, Adrienne; Musgrove, Elizabeth A.; Nagrial, Adnan; Nones, Katia; Pajic, Marina; Patch, Anne-Marie; Pearson, John V; Pinese, Mark; Rooman, Ilse; Samra, JS; Waddell, Nic; Wasan, Harpreet; Wu, Jianmin; Deans Unit: (CIPHER); Northern Clinical School: Kolling InstituteClinical and molecular characterization of HER2 amplified-pancreatic cancer, Genome Medicine, vol.5, 8, 2013,pp 1-11
2010Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.McNeil, Catriona; O'Toole, Sandra; Crea, Paul; Lopez-Knowles, Elena; Millar, E.; Musgrove, Elizabeth A.; Sutherland, Robert L.; Zardawi, Sarah J; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyCytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients., Cancer Epidemiology, Biomarkers & Prevention, vol.19, 1,pp 301-309
2011Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast CancerCooper, Caroline; O'Toole, Sandra; Christ, Daniel; Hannigan, Gregory E.; Machalek, Dorothy A.; Martelotto, Luciano G.; McFarland, Andrea; McLeod, Duncan; McNeil, Catriona M.; Millar, Ewan; Musgrove, Elizabeth A.; Nair, Radhika; Nguyen, Akira; Ormandy, Christopher J.; Qiu, Min Ru; Rabinovich, Brian; Schofield, Peter R.; Shearer, Robert F.; Sutherland, Robert L.; Swarbrick, A.; Vu, Duc; Watkins, D. Neil; Central Clinical School: Pathology; Central Clinical School: PathologyHedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer, Cancer Research, vol.71, 11, 2011,pp 4002-4014
2010High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeHamilton, Anne; Lee, Cheok; McNeil, Catriona; Spillane, Andrew; Crea, P; Lopez-Knowles, Elena; McLeod, Duncan; Millar, Ewan; Morey, Adrienne; Murphy, N C; Musgrove, Elizabeth A.; Oakes, Samantha; Ormandy, Christopher J.; O'Toole, Sandra; Pinese, Mark; Qiu, Min; Sutherland, Robert L.; Zardawi, Ibrahim; Zardawi, Sarah J; Central Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineHigh Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype, Histopathology, vol.56, 3,pp 286-296
2011Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancerMcNeil, Catriona; O'Toole, Sandra; Butt, Alison Joy; Lehrbach, Gillian M.; McCloy, R. A.; Millar, E. K. A.; Musgrove, Elizabeth A.; Pinese, Mark; Roberts, C. G.; Sutherland, Robert L.; Tobelmann, P; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyIdentification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer, Oncogene: including Oncogene Reviews, vol.30, 28, 2011,pp 3186-3197
2010PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortalityO'Toole, Sandra; Crea, Paul; Daly, Roger; Lopez-Knowles, Elena; McNeil, Catriona; Millar, E.; Musgrove, Elizabeth A.; Qiu, Min Ru; Sutherland, Robert L.; Central Clinical School: PathologyPI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality, International Journal of Cancer, vol.126, 5,pp 1121-1131
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan; O'Toole, Sandra; Castiglione-Gertsch, Monica; Gelber, Richard; Goldhirsch, Aron (Prof); Gusterson, Barry; Millar, E. K. A.; Molloy, T; Musgrove, Elizabeth A.; Regan, Meredith M.; Sun, Zhuoxin; Sutherland, Robert L.; Viale, Giuseppe; School of Public Health: Public Health; Central Clinical School: PathologyPrognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX, Breast Cancer Research, vol.14, 6, 2012,pp 1-12
2015Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filamentsCoombes, Jason; Schevzov, Galina; Assoian, Richard K.; Cretu, Alexandra; et al, Various; Hook, Jeff; Kee, Anthony; Lucas, Christine; Musgrove, Elizabeth A.; Sequeira, Vanessa; Stehn, Justine; Wang, Bin; Western Clinical School: Medicine (Westmead); Childrens Hospital Westmead: Paediatrics & Child HealthRegulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments, Molecular Biology of the Cell, vol.26, 13, 2015,pp 2475-2490
2011Retinoid signaling in pancreatic cancer, injury and regenerationKench, James; O'Toole, Sandra; Apte, M V; Biankin, Andrew; Chang, David K.; Colvin, E K; Mawson, Amanda; Musgrove, Elizabeth A.; Ong, Vivienna N; Pinese, Mark; Rooman, Ilse; Scarlett, C J; Segara, Davendra; Susanto, J; Sutherland, Robert L.; School of Medical Sciences: Pathology; Central Clinical School: PathologyRetinoid signaling in pancreatic cancer, injury and regeneration, PLoS One, vol.6, 12, 2011,pp e29075 - 1-e29075 - 10